Not Yet Recruiting PHASE2 INTERVENTIONAL 2-arm
NCT07447102
Phase II Clinical Study of BC006 in Patients With Idiopathic Pulmonary Fibrosis
A Phase II Clinical Study to Evaluate the Efficacy and Safety of BC006 in Patients With Idiopathic Pulmonary Fibrosis
Sponsor: Dragonboat Biopharmaceutical Company Limited
Conditions
Idiopathic Pulmonary Fibrosis (IPF)
Updated 1 time since 2026 Last updated: Feb 27, 2026 Started: Apr 1, 2026 Primary completion: Apr 1, 2029 Completion: Apr 1, 2029
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A PHASE2 clinical study on Idiopathic Pulmonary Fibrosis (IPF), this trial is actively recruiting participants. The trial is conducted by Dragonboat Biopharmaceutical Company Limited and has accumulated 1 data snapshot since 2026. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
1 version recorded Not Yet Recruiting — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Dragonboat Biopharmaceutical Company Limited
Data source: Dragonboat Biopharmaceutical Company Limited
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
No location information available.